Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Official Title: Safety and Efficacy Evaluation Study of FYU-981 Long-term Administration for Hyperuricemia With or Without Gout (Phase III Study)

NCT03006445 is registered in ClinicalTrials.gov with Fuji Yakuhin Co., Ltd. as lead sponsor.

NCT NCT03006445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03006445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Official Title: Safety and Efficacy Evaluation Study of FYU-981 Long-term Administration for Hyperuricemia With or Without Gout (Phase III Study)
Lead sponsor
Fuji Yakuhin Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2016
Completion date
October 24, 2018
Enrollment
330 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperuricemia with or without gout